DJIA 16,415.47 -9.38 -0.06%
NASDAQ 4,096.19 9.97 0.24%
S&P 500 1,864.20 1.89 0.10%
market minute promo

63.81 0.91 (1.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LGND $63.81 1.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $62.51
Previous Close $62.90
Daily Range $61.28 - $66.21
52-Week Range $23.87 - $80.42
Market Cap $1.3B
P/E Ratio 146.28
Dividend (Yield) $0.00 (0.0%)
Volume 125,443
Average Daily Volume 349,142
Current FY EPS $1.11

Sector

Healthcare

Industry

Drugs

Ligand Pharmaceuticals, Inc. (LGND) Description

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases. Website: http://www.ligand.com/

News & Commentary

2 Health Care Partnerships Go Head-To-Head

While the partnership between GlaxoSmithKline (NYSE: GSK) and Ligand (NASDAQ: LGND) seems to be moving forward, the partnership between Roche (OTCMKTS: RHHBY) and PDL (NASDAQ: PDLI) has seemingly reached its end

Insider Trading Alert - VLO, LGND And DAR Traded By Insiders

Milestone Payment for Ligand Pharma - Analyst Blog

Ligand Pharmaceuticals: A Biotech Cash Cow

Bright Outlook at Ligand - Analyst Blog

Commit To Buy Ligand Pharmaceuticals At $65, Earn 22.6% Annualized Using Options

Glaxo/Ligand Look to Expand Promacta Label - Analyst Blog

Ligand Pharmaceuticals - Priced To Perfection Or More Room To Run?

Insider Trading Alert - LCI, POWI And LGND Traded By Insiders

Ligand Pharmaceuticals: 2014 Run Not Done With Short And Long-Term Catalysts Coming

Ligand Pharmaceuticals: 5 Different Insiders Have Sold Shares This Month

See More LGND News...

LGND's Top Competitors

LGND $63.81 (1.45%)
Current stock: LGND
AMGN $115.64 (0.09%)
Current stock: AMGN
GILD $69.71 (0.62%)
Current stock: GILD
CELG $141.95 (0.06%)
Current stock: CELG